LBPH Stock Summary and Trading Ideas (Longboard Pharmaceuticals | NASDAQ:LBPH)

Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.

Longboard Pharmaceuticals trades on the NASDAQ stock market under the symbol LBPH.

As of December 11, 2024, LBPH stock price was flat at $59.98 with million shares trading.

LBPH has a beta of -0.99, meaning it tends to be less sensitive to market movements. LBPH has a correlation of 0.01 to the broad based SPY ETF.

LBPH has a market cap of $2.34 billion. This is considered a Mid Cap stock.

In the last 3 years, LBPH traded as high as $60.03 and as low as $2.70.

The top ETF exchange traded funds that LBPH belongs to (by Net Assets): VTI, VXF, VTWO, VHT, VTWG.

LBPH has outperformed the market in the last year with a return of +1173.5%, while the SPY ETF gained +33.0%. In the last 3 month period, LBPH beat the market returning +78.5%, while SPY returned +9.9%. However, in the most recent 2 weeks LBPH has underperformed the stock market by returning 0.0%, while SPY returned +1.4%.

LBPH support price is $59.92 and resistance is $60.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LBPH shares will trade within this expected range on the day.